1. Home
  2. CNTB vs DLHC Comparison

CNTB vs DLHC Comparison

Compare CNTB & DLHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • DLHC
  • Stock Information
  • Founded
  • CNTB 2012
  • DLHC 1969
  • Country
  • CNTB United States
  • DLHC United States
  • Employees
  • CNTB N/A
  • DLHC N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • DLHC Business Services
  • Sector
  • CNTB Health Care
  • DLHC Consumer Discretionary
  • Exchange
  • CNTB Nasdaq
  • DLHC Nasdaq
  • Market Cap
  • CNTB 90.3M
  • DLHC 80.0M
  • IPO Year
  • CNTB 2021
  • DLHC N/A
  • Fundamental
  • Price
  • CNTB N/A
  • DLHC $5.66
  • Analyst Decision
  • CNTB Strong Buy
  • DLHC
  • Analyst Count
  • CNTB 2
  • DLHC 0
  • Target Price
  • CNTB $7.50
  • DLHC N/A
  • AVG Volume (30 Days)
  • CNTB 88.0K
  • DLHC 16.5K
  • Earning Date
  • CNTB 11-13-2025
  • DLHC 08-06-2025
  • Dividend Yield
  • CNTB N/A
  • DLHC N/A
  • EPS Growth
  • CNTB N/A
  • DLHC 80.25
  • EPS
  • CNTB N/A
  • DLHC 0.31
  • Revenue
  • CNTB $1,965,000.00
  • DLHC $359,723,000.00
  • Revenue This Year
  • CNTB N/A
  • DLHC N/A
  • Revenue Next Year
  • CNTB $453,067.90
  • DLHC N/A
  • P/E Ratio
  • CNTB N/A
  • DLHC $18.00
  • Revenue Growth
  • CNTB N/A
  • DLHC N/A
  • 52 Week Low
  • CNTB $1.23
  • DLHC $2.72
  • 52 Week High
  • CNTB $2.20
  • DLHC $9.58
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 58.99
  • DLHC 48.87
  • Support Level
  • CNTB $1.36
  • DLHC $5.58
  • Resistance Level
  • CNTB $1.88
  • DLHC $5.60
  • Average True Range (ATR)
  • CNTB 0.15
  • DLHC 0.10
  • MACD
  • CNTB 0.04
  • DLHC -0.01
  • Stochastic Oscillator
  • CNTB 99.48
  • DLHC 15.30

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About DLHC DLH Holdings Corp.

DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.

Share on Social Networks: